At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Mar 13, 2026 at 16:01 ET
This DEFA14A filing is a definitive additional proxy soliciting material from Abbott Laboratories (ABT), indicating it contains supplementary information related to an upcoming shareholder vote. The filing appears to be routine corporate governance documentation, likely related to director elections or executive compensation, but the provided documents do not contain specific financial data or details about the vote's agenda.
- Filing is a DEFA14A, which is a definitive additional proxy soliciting material.
- Filed by the registrant (Abbott Laboratories).
- No specific details about the shareholder vote agenda are provided in the available documents.
- The filing is routine and relates to corporate governance.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access